Brawn Biotech Ltd

₹ 22.0 1.95%

10 Oct - close price

About

Incorporated in 1985, Brawn Biotech Ltd is in the business of trading pharmaceutical products^[1]

Key Points

Business Overview:^[1]
BBL is a fully integrated healthcare company that deals in pharmaceutical products, covering segments:
a) Antibacterial
b) Cardiovascular
c) Antidiabetics
d) Analgesics
e) Gastrointestinal
f) Antifungals
g) Skin Care
h) Antipsychotics,
i) Anti-asthmatics
j) Antacids
k) Antimalarial
l) Nutritional

Website BSE

Market Cap ₹ 6.60 Cr.
Current Price ₹ 22.0
High / Low ₹ 26.0 / 15.5
Stock P/E
Book Value ₹ 11.2
Dividend Yield 0.00 %
ROCE -42.5 %
ROE -41.3 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.

Cons

Company has low interest coverage ratio.
Company has a low return on equity of -23.1% over last 3 years.
Working capital days have increased from 145 days to 216 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	0.12	7.77	6.31	4.75	7.29	2.92	2.84	3.45	4.06	3.30	3.84	2.26	5.80
	0.09	8.11	6.32	4.88	7.45	3.31	3.42	3.84	4.56	3.62	4.24	2.81	5.62
Operating Profit	0.03	-0.34	-0.01	-0.13	-0.16	-0.39	-0.58	-0.39	-0.50	-0.32	-0.40	-0.55	0.18
OPM %	25.00%	-4.38%	-0.16%	-2.74%	-2.19%	-13.36%	-20.42%	-11.30%	-12.32%	-9.70%	-10.42%	-24.34%	3.10%
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.00	0.00	0.00	0.09	0.09
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.02	0.03	0.04	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Profit before tax	0.03	-0.36	-0.04	-0.17	-0.18	-0.42	-0.61	-0.34	-0.53	-0.35	-0.43	-0.49	0.24
Tax %	0.00%	-2.78%	0.00%	258.82%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.02	-0.35	-0.04	-0.61	-0.17	-0.42	-0.61	-0.34	-0.53	-0.34	-0.43	-0.49	0.24
EPS in Rs	0.07	-1.17	-0.13	-2.03	-0.57	-1.40	-2.03	-1.13	-1.77	-1.13	-1.43	-1.63	0.80
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	34.42	38.65	46.88	59.78	55.71	65.18	49.62	34.98	8.53	22.23	16.49	13.46	15.20
	33.97	38.09	45.44	58.53	53.75	64.01	48.89	35.58	10.53	22.53	17.95	15.23	16.29
Operating Profit	0.45	0.56	1.44	1.25	1.96	1.17	0.73	-0.60	-2.00	-0.30	-1.46	-1.77	-1.09
OPM %	1.31%	1.45%	3.07%	2.09%	3.52%	1.80%	1.47%	-1.72%	-23.45%	-1.35%	-8.85%	-13.15%	-7.17%
	-0.07	0.04	0.01	0.61	0.09	0.74	0.17	0.31	0.00	0.01	0.08	0.09	0.18
Interest	0.14	0.10	0.11	0.07	0.06	0.07	0.05	0.04	0.06	0.01	0.06	0.00	0.00
Depreciation	0.01	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.05	0.11	0.10	0.11	0.12
Profit before tax	0.23	0.47	1.31	1.76	1.96	1.81	0.82	-0.36	-2.11	-0.41	-1.54	-1.79	-1.03
Tax %	39.13%	40.43%	27.48%	20.45%	34.69%	26.52%	28.05%	55.56%	-22.27%	109.76%	-19.48%	-3.35%
	0.14	0.28	0.95	1.39	1.28	1.33	0.59	-0.55	-1.64	-0.87	-1.25	-1.74	-1.02
EPS in Rs	0.47	0.93	3.17	4.63	4.27	4.43	1.97	-1.83	-5.47	-2.90	-4.17	-5.80	-3.39
Dividend Payout %	0.00%	0.00%	31.58%	32.37%	23.44%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-10%
5 Years:	-23%
3 Years:	16%
TTM:	15%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	-2%
TTM:	46%

Stock Price CAGR
10 Years:	-5%
5 Years:	-2%
3 Years:	5%
1 Year:	6%

Return on Equity
10 Years:	-1%
5 Years:	-18%
3 Years:	-23%
Last Year:	-41%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00
Reserves	1.68	1.94	2.53	3.92	4.63	5.66	6.26	5.79	4.22	3.31	2.06	0.36
	0.01	0.11	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	9.00	8.95	8.30	10.11	14.94	13.85	11.03	5.08	6.56	8.22	9.53	17.13
Total Liabilities	13.69	14.00	13.95	17.03	22.57	22.51	20.29	13.87	13.78	14.53	14.59	20.49
	0.07	0.19	0.24	0.25	0.22	0.19	0.18	0.14	0.39	0.37	0.33	0.46
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.03	0.03	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	13.59	13.78	13.68	16.78	22.35	22.32	20.11	13.73	13.39	14.16	14.26	20.03
Total Assets	13.69	14.00	13.95	17.03	22.57	22.51	20.29	13.87	13.78	14.53	14.59	20.49

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	0.18	0.23	0.05	1.37	-1.54	0.21	-0.08	0.03	0.19	0.32	-0.03	0.05
	-0.01	-0.12	-0.08	0.57	0.00	0.00	-0.02	0.00	-0.30	-0.10	-0.01	-0.24
	-0.15	0.00	-0.05	-0.11	-0.06	-0.06	-0.05	-0.04	-0.06	-0.01	0.00	0.00
Net Cash Flow	0.02	0.11	-0.08	1.83	-1.60	0.15	-0.14	0.00	-0.17	0.21	-0.04	-0.20

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	88.65	87.07	71.63	79.50	98.60	92.17	110.34	96.83	120.24	87.35	85.88	92.47
Inventory Days	22.14	11.17	4.50	2.59	2.62	2.12	3.38	3.16	261.82	91.20	153.02	320.33
Days Payable	87.79	73.72	44.59	47.70	83.93	64.58	74.47	32.34	224.66	123.19	144.12	252.10
Cash Conversion Cycle	23.01	24.52	31.54	34.39	17.29	29.72	39.25	67.65	157.41	55.36	94.78	160.70
Working Capital Days	15.48	15.87	18.92	28.21	43.37	42.06	58.04	77.53	241.76	80.62	137.90	216.40
ROCE %	24.89%	11.91%	26.54%	29.28%	27.77%	23.08%	9.71%	-3.55%	-25.61%	-5.91%	-25.86%	-42.52%

Shareholding Pattern

Numbers in percentages

	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
	53.73%	53.72%	53.72%	53.72%	53.72%	53.72%	53.64%	53.64%	53.64%	53.64%	53.66%	53.66%
	0.59%	0.59%	0.59%	0.59%	0.59%	0.59%	0.35%	0.35%	0.35%	0.35%	0.35%	0.35%
	45.67%	45.69%	45.69%	45.69%	45.69%	45.69%	46.02%	46.02%	46.02%	46.02%	46.01%	46.00%
No. of Shareholders	6,281	6,275	6,222	6,246	6,194	6,139	4,160	4,090	4,157	4,060	4,024	3,975

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Jun 2025
	53.68%	53.39%	53.70%	53.71%	53.71%	53.71%	53.72%	53.64%	53.66%	53.66%
	0.59%	0.59%	0.59%	0.59%	0.59%	0.59%	0.59%	0.35%	0.35%	0.35%
	45.73%	46.02%	45.70%	45.69%	45.69%	45.69%	45.69%	46.02%	46.01%	46.00%
No. of Shareholders	6,237	6,219	6,150	6,074	5,991	6,288	6,222	4,160	4,024	3,975

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Brawn Biotech Ltd

Brawn Biotech Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports